Sanofi Industry Symposiumadmin2020-07-27T10:34:28+00:00
Sanofi Industry Symposium
How to optimize the treatment sequence in Relapsed and Refractory Multiple Myeloma patients – Evidence based Medicine.
October 4th, 2020 – 12:30 to 14:00
Chairs: Mohamad Mohty and Hermann Einsele
First line treatment options and how they impact the following treatment decisions Thierry Facon
The role of Pomalidomide in the treatment of Lenalidomide-refractory multiple myeloma. Maria Vitoria Mateos
AntiCD38 antibody therapy in Lenalidomide-Refractory Multiple Myeloma patients: evidence-based therapy considerations Philippe Moreau
Health-related quality of life in patients with relapsed/refractory multiple myeloma Kwee Yong
Q&A and Panel discussion “How to optimize the treatment sequence in Relapsed-and Refractory Multiple Myeloma patients”. Moderator: Mohamad Mohty Panel: Hermann Einsele, Thierry Facon, Philippe Moreau, Maria Vitoria Mateos, Kwee Yong
Given the escalation of the spread of COVID-19 and the global uncertainty, the COMy Organizing Committee has decided that instead of an in-person COMy Congress in October COMy will become a FULLY virtual meeting on this platform.
Click here to register for the Virtual COMy meeting on October 3-4, 2020.